Mariner
MIST icon

Mariner’s Milestone Pharmaceuticals MIST Stock Holding History

Mariner’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.2K Sell
27,830
-3,000
-10% -$4.8K ﹤0.01% 3441
2026
Q1 		$36.7K Buy
30,830
+5,830
+23% +$10.2K ﹤0.01% 3452
2025
Q4 		$50.5K Hold
25,000
– – ﹤0.01% 3412
2025
Q3 		$50K Buy
25,000
+14,000
+127% +$24.6K ﹤0.01% 3447
2025
Q2 		$21.3K Buy
+11,000
New +$14.7K ﹤0.01% 3417

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Mariner's MIST Position: Q2 2026 in Review

Mariner reduced its Milestone Pharmaceuticals (MIST) stake by 9.7% in Q2 2026, selling an estimated $4.8K and leaving 27,830 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

Mariner first reported a position in MIST in Q2 2025 and has held it in 5 quarters since. The position peaked at $50.5K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Mariner held 27,830 shares of Milestone Pharmaceuticals worth $37.2K as of Q2 2026.
  • Mariner sold 3,000 Milestone Pharmaceuticals shares in Q2 2026, an estimated $4.8K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3441 holding.
  • Mariner first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Mariner's Milestone Pharmaceuticals position peaked at $50.5K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.